The number of people with susceptibility test result for rifampicin in Estonia
Estonia: The number of people with susceptibility test result for rifampicin was 74 in 2021. ▼ Falling
Latest (2021)
74
Change on year
down 18.7%
World rank
113th
of 155 countries
All-time high
123
in 2017
All-time low
74
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Estonia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Estonia is 74, measured in 2021. That is the lowest value across all 5 years on record.
That represents a change of down 18.7% on the previous year and down 39.8% over five years.
Estonia ranks 113th of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Estonia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 123 | — |
| 2018 | 104 | -15.4% |
| 2019 | 106 | +1.9% |
| 2020 | 91 | -14.2% |
| 2021 | 74 | -18.7% |
Estonia compared with similar countries
- Estonia's 74 is below the median for high income countries, which is 142, 52% of the median. (61 countries reporting)
- Estonia's 74 is below the median for Europe & Central Asia, which is 229.5, 32% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 111 | 104 | 123 | 3 |
| 2020s | 82.5 | 74 | 91 | 2 |
Countries ranked near Estonia
More health data for Estonia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.02 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,416 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -6.8 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.021 units per person (2025)
- Population ages 00-04, male, annual growth rate -6.34 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Estonia?
- The number of people with susceptibility test result for rifampicin in Estonia was 74 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Estonia?
- The highest recorded value was 123 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Estonia?
- The lowest recorded value was 74 in 2021.
- How does Estonia rank for the number of people with susceptibility test result for rifampicin?
- Estonia ranks 113th out of 155 countries with data for 2021.
- Where does this Estonia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).